Acquired von Willebrand Syndrome in Aortic Stenosis - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Acquired von Willebrand Syndrome in Aortic Stenosis

Description:

Acquired von Willebrand Syndrome in Aortic Stenosis The New England Journal of Medicine July 24th , 2003 Von Willebrand Disease vWD is due to an abnormality ,either ... – PowerPoint PPT presentation

Number of Views:204
Avg rating:3.0/5.0
Slides: 35
Provided by: Libr90
Category:

less

Transcript and Presenter's Notes

Title: Acquired von Willebrand Syndrome in Aortic Stenosis


1
Acquired von Willebrand Syndrome in Aortic
Stenosis
  • The New England Journal of Medicine
  • July 24th , 2003

2
Von Willebrand Disease
  • vWD is due to an abnormality ,either
    quantitative ,absence or qualitative of the vWf.
  • vWf is a large multimeric glycoprotein that
    function as
  • 1.the factor Vlll carrier protein (vWf protect
    factor Vlll from degradation).
  • 2. required for normal platelet adhesion (vWf
    binds on platelet to its specific
    receptor glycoprotein lb acts as
    adhesive bridge between the
    platelet damaged sub-
    endothelium at the site of vascular injury

3
  • vWf is composed of dimeric subunits that are
    linked by disulfide bonds to form complex
    multimers of low ,intermediate high molecular
    weights .
  • The small multimers function mainly as carriers
    for factor Vlll.

4
  • High molecular weight multimers have higher
    numbers of platelet-binding sites greater
    adhesive properties .
  • Each multimeric subunit has binding sites for
    the receptor glycoprotein lb on non-activated
    platelets the receptor glycoprotein llb/llla on
    activated platelets,
  • this facilitates both platelet adhesion
    aggregation .

5
Acquired forms of vWD
  • 1. Wilms tumor.
  • 2. Congenital hear disease.
  • 3. Systemic lupus erythmatosus.
  • 4. Angiodysplasia.
  • 5. Seizures disorders treated with valproate.
  • 6. Hypothyroidism.

6
ABSRACT
  • Background
  • Aortic-valve Stenosis can be complicated by
    bleeding that is associated with acquired type 2A
    von Willebrand syndrome . However, the prevalence
    cause of the haemostatic abnormality in aortic
    Stenosis are unknown .

7
Methods
  • We enrolled 50 consecutive patients with aortic
    Stenosis, who completed a standardized screening
    questionnaire to detect a H/O bleeding. 42
    patients with sever aortic Stenosis underwent
    valve replacement.

8
  • Platelets function under conditions of high shear
    stress, vWf collagen-binding activity Ag
    levels, the multimeric structure of vWf were
    assessed _at_ base line 1 day, 7 days, six
    months post-operatively.

9
Results
  • Skin or mucosal bleeding occurred in 21 of the
    patients with sever aortic Stenosis.
    Platelets-function abnormalities under condition
    of high shear stress, decreased vWf
    collagen-binding activity the loss of the
    largest multimers, or a combination of these was
    present in 67 92 of patients with sever
    aortic Stenosis correlated significantly with
    the severity of valve Stenosis.

10
  • 1ry haemostatic abnormalities were completely
    corrected on the 1st day after surgery but tended
    to recur _at_ 6/12, especially when there was a
    mismatch between pt. prosthesis (with an
    effective orifice area of lt 0.8 cm2/m2/BSA)

11
Conclusions
  • Type 2A vW Syndrome is common in patients with
    sever aortic Stenosis.
  • vWf abnormalities are directly related to the
    severity of aortic Stenosis are improved by
    valve replacement in the absence of mismatch
    between patient prosthesis.

12
  • Aortic-valve Stenosis can be commonly
    complicated by bleeding
  • 1. G. I. Angiodysplasia Heydes syndrome.
  • 2. Proteolysis of vWf as it passes via the
    Stenotic valve.

13
METHODS patients
  • Between 3 7/2001, 50 consecutive pts (20 F
    30 M)referred for evaluation of aortic Stenosis
    were enrolled in the study.
  • pts were excluded if they were lt18 year old or
    not competent to give consent, had active
    endocarditis, had multivalvular disease, had ass.
    Coronary disease, or were receiving anti-platelet
    treatment that couldnt be stopped 10 days before
    surgery.

14
  • 42 patients (18 F 24 M, 70 /-10 years) had
    sever aortic Stenosis subsequently underwent
    aortic-valve replacement .
  • 8 Patients ( 66 /- years) had only moderate
    aortic Stenosis did not undergo surgery.

15
METHODS screening for bleeding diathesis
  • Each patients bleeding symptoms were evaluated
    by the use of a standardized screening
    questionnaire.
  • Only bleeding during the 6 months preceding
    evaluation was repeated six months
    post-operatively in group undergoing surgery.

16
METHODS Echo. evaluation
  • One investigator assessed the hemodynamic
    performance of the aortic valve by
    trans-thoracic echo. _at_ base line _at_ 6 months
    post-operatively in the surgical group.

17
  • The mean peak transvalvular pr. Gradients were
    calculated with Bernoulli equation,the effective
    orifice area was calculated by the continuity
    equation the wall shear stress.
  • At six months post-operatively, a mismatch
    between the patient prosthesis was defined as
    an indexed effective orifice area of lt 0.8 cm2
    /m2/BSA.

18
(No Transcript)
19
METHODS blood collecting lab. Assays
  • In patients with sever A. Stenosis, blood samples
    were collected the day before the surgery one
    day, 7 days 6 months after surgery.
  • In patients with moderate A. Stenosis, blood
    samples were collected on the day of Echo.

20
  • Platelet-related hemostasis was tested with a
    platelet-analyzer (a high shear system for in
    vitro testing of platelet function that stimulate
    1ry hemostasis after injury to a small vessel) by
    determining closure time of adenine di-phosphate
    cartilages.
  • It is highly sensitive way to screen pts with
    vWf defect.

21
  • Plasma vWf Ag was measured by immuno-tubidimetry,
    factor Vlll coagulant activity by 1 stage
    clotting assay with factor Vlll -deficient
    plasma.
  • The multimeric structure of plasma vWf was
    analyzed by electrophoresis with 0.15 Na dodicyl
    sulfate 1.5 agarose gel.

22
RESULTS bleeding prevalence
  • Among the 42 pts with sever Aortic Stenosis ,
    11 had episodes of bleeding in the 6 months
    before surgery. In 2 , the bleeding episode
    occurred during oral anti-coagulant treatment
    was not taken into account in further analysis.

23
  • Thus,9 of 42 pts had _at_ least 1 episode of
    bleeding.
  • One pt. had a H/O major bleeding (epistaxis)
    that needed a blood transfusion.
  • Among the 8 pts with moderate aortic Stenosis,
    two had H/O hemorrhagic syndrome,both while
    receiving anti-platelets agents.

24
RESULTS Surgical treatment
  • 11 pts 65 yrs of age or younger received a
    mechanical bileaflet prosthetic device, 31 pts
    gt 65 yrs if age received a biologic device 29
    pericardial valves/ 1 stentless porcine valve,
    1 cryopreserved aortic homograft.
  • Mechanical devices were implanted in 3 pts with
    a preoperative H/O bleeding.

25
RESULTS immediate postoperative course
  • The blood loss 24 hrs after replacement was 120
    to 1580 ml.
  • One pt. Underwent re-operation for bleeding on
    the day after surgery.
  • One other pt. Died from V.F. 10 days after
    surgery.
  • The multimeric pattern of vWf determined in 1
    pt. 3 hrs after surgery was also normalized.

26
  • the postoperative blood loss was significantly
    higher in pts with preoperative bleeding than in
    those without preoperative bleeding 195 to 1580
    ml versus 120 to 700 ml.
  • 6 pts, all with a preoperative H/O bleeding,
    had a blood loss greater than 700 ml.

27
RESULTS follow-up _at_ 6/12 N pts who underwent
surgery
  • Two pts were lost to follow-up _at_ 6 months .
  • One pt. Presented with early homograft valve
    Stenosis that required reoperation _at_ 6/12.in this
    pt., repeated epistaxis was observed _at_ the onset
    of restenosis.

28
  • The other 38 pts were a symptomatic _at_ 6 months,
    without bleeding episodes, even those who had a
    preoperative H/O bleeding had a mechanical
    prosthesis requiring oral anticoagulant therapy.
  • A mismatch between pt. prosthesis was observed
    in 10 cases

29
  • _at_ 6 months the platelet count were normal .
  • The platelet-function-analyzer values, were
    abnormal in 66 of the pts.

30
DISCUSSION
  • This study evaluate the frequency
    determinants of acquired vW Syndrome bleeding
    in consecutive pts with A. Stenosis .
  • Careful investigation showed that bleeding
    (mostly from skin mucosa) was present in 20 of
    the pts with sever A. Stenosis

31
  • Moreover, prolongation of the platelet-function
    analyzer closure time ( a measure of platelet
    function under high shear stress conditions ),
    abnormalities of vWf , or both were common in
    sever aortic Stenosis

32
  • We also demonstrated that vWf abnormalities
    increased with the pr. gradient the
    Stenosis-induced shear stress, indicating that
    vWf abnormalities are related to the severity of
    the A. Stenosis .
  • Together, these data suggest that the
    haemostatic defect is related mostly to direct
    proteolysis of the largest multimers of vWf.

33
  • The present study demonstrates that acquired vW
    Syndrome is a consequence of the mechanical
    obstruction of blood flow that homeostatic
    abnormalities bleeding are symptoms of sever
    Stenosis.

34
The End
  • thanks
Write a Comment
User Comments (0)
About PowerShow.com